InvestorsHub Logo

RIGATONI

05/10/24 9:29 AM

#380550 RE: RIGATONI #380549

This hit $2.39 Wednesday from my low alert on this News...

CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer

I guess shorts hit it maybe counting on a financing like we see so often after news.

But now, the insiders are buying open market stock which means there isnt any financing right now imo.

https://finance.yahoo.com/news/cel-sci-receives-fda-ahead-130000511.html